News
Talecris Biotherapeutics honored with "Art of Industry Partnership Award" for years of work with Alpha-1 community
WASHINGTON, DD – Genetic Alliance, a nonprofit health advocacy organization, announced that Joseph D. McInerney, Frank Lehmann-Horn, Gautam Naik, and Talecris Biotherapeutics will be honored for their contributions to the genetics community at the 2009 Genetic Alliance Awards Banquet on July 18, 2009.
The Art of Industry Partnership Award will recognize Talecris Biotherapeutics for supporting creative partnerships in advancing the understanding and treatment of genetic conditions, disorders and diseases.
Talecris, the manufacturer of the Alpha-1 augmentation therapy Prolastin, was nominated for the award by the Alpha-1 Foundation, whose President and CEO, John Walsh, said today, “Talecris has been a highly valued industry partner for the Alpha-1 community for many years and is highly deserving of this award.”
The company helped the Alpha-1 Foundation to create the world’s largest Alpha-1 research registry and supported the development of educational materials, while offering grants to Alpha-1 groups and awareness campaigns in North America and Europe.
“Their 17-year partnership with the Alpha-1 community is a hallmark of the Talecris commitment to advocacy organizations,” the press release said.
Lawrence Stern, chairman and chief executive officer of Talecris, will accept on behalf of the organization.
